Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

In Vivo T Cell Depletion with Thymoglobulin or Alemtuzumab Is Associated with Worse Outcome Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients Transplanted in Remission

Scott R. Solomon, MD, Melissa Sanacore, Pharm.D., Xu Zhang, PhD, Katelin Connor, Melhem Solh, MD, Lawrence E. Morris, MD, H. Kent Holland, MD, Asad Bashey, MD PhD

Blood (2015) 126 (23): 3115.

https://doi.org/10.1182/blood.V126.23.3115.3115

Published: 2015

Journal Articles

Disease Risk and Host Factors, Not Transplant Type, Predict Outcome Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia

Scott R. Solomon, MD, Connie Sizemore, Xu Zhang, Katelin Connor, Melhem Solh, MD, H. Kent Holland, MD, Lawrence E. Morris, MD, Asad Bashey, MD PhD

Blood (2015) 126 (23): 4372.

https://doi.org/10.1182/blood.V126.23.4372.4372

Published: 2015

Journal Articles

Factors Predicting Gvhd Free, Relapse Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation; A Multivariable Analysis of 531 Allografts from a Single Center

Melhem Solh, MD, Xu Zhang, PhD, Katelin Connor, Stacey Brown, B.A., H. Kent Holland, MD, Lawrence E. Morris, MD, Scott R. Solomon, MD, Asad Bashey, MD PhD

Blood (2015) 126 (23): 2028.

https://doi.org/10.1182/blood.V126.23.2028.2028

Published: 2015

Journal Articles

T Cell Replete HLA- Haploidentical Donor Transplantation (HIDT) with Post-Transplant Cyclophosphamide (pTcy) Is an Effective Salvage for Patients Relapsing after a Matched Sibling or a Matched Unrelated Donor Transplantation

Melhem Solh, MD, Katelin Connor, Xu Zhang, PhD, Stacey Brown, B.A., Lawrence E. Morris, MD, H. Kent Holland, MD, Asad Bashey, MD PhD, Scott R. Solomon, MD

Blood (2015) 126 (23): 1960.

https://doi.org/10.1182/blood.V126.23.1960.1960

Published: 2015

Journal Articles

Targeted Oral Busulfan (BU)/Cyclophosphamide (CY)/VP-16 and Autologous Stem Cell Transplant (ASCT) for Hodgkin's (HL) and Non-Hodgkin's Lymphoma (NHL) Results in Excellent 5-Year Survival and Low Treatment-Related Mortality: Ten-Year Single Center Experience of 246 Consecutively Treated Patients

Scott R. Solomon, MD, Sanacore Melissa, Xu Zhang, Katelin Connor, Melhem Solh, MD, Asad Bashey, MD PhD, Lawrence E. Morris, MD, H. Kent Holland, MD

Blood (2015) 126 (23): 3185.

https://doi.org/10.1182/blood.V126.23.3185.3185

Published: 2015

Journal Articles

TBI-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients without Matched Sibling Donors

Scott R. Solomon, MD, Connie Sizemore, PharmD, Xu Zhang, PhD, Stacey Brown, B.A., Katelin Connor, B.S., Lawrence E. Morris, MD, H. Kent Holland, MD, Asad Bashey, MD PhD

Blood (2014) 124 (21): 426.

https://doi.org/10.1182/blood.V124.21.426.426

Published: 2014

Journal Articles

Use of the Dana-Farber/CIBMTR Disease Risk Index (DRI) to Compare Outcomes of T-Replete HLA-Haploidentical Transplants Using Post-Transplant Cyclophosphamide to Matched Sibling and Matched Unrelated Donor Transplants : A Multivariate Analysis of 498 Contemporaneous Allogeneic Transplants from a Single Center

Asad Bashey, MD PhD, Xu Zhang, PhD, Stacey Brown, B.A., Katelin Connor, Lawrence E. Morris, MD, H. Kent Holland, MD, Scott R. Solomon, MD

Blood (2014) 124 (21): 1203.

https://doi.org/10.1182/blood.V124.21.1203.1203

Published: 2014

Journal Articles

Chronic GVHD Is Not Increased with the Use of PBSC Instead of Bone Marrow for T-Replete HLA-Haploidentical Transplanation Using Post-Transplant Cyclophosphamide : A Multivartiate Analysis of 116 Consecutive Transplants from a Single Center

Asad Bashey, MD PhD, Xu Zhang, PhD, Stacey Brown, B.A., Katelin Connor, Lawrence E. Morris, MD, H. Kent Holland, MD, Ridgeway Michelle, RN, Scott R. Solomon, MD

Blood (2014) 124 (21): 3922.

https://doi.org/10.1182/blood.V124.21.3922.3922

Published: 2014

NARROW

In Vivo T Cell Depletion with Thymoglobulin or Alemtuzumab Is Associated with Worse Outcome Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients Transplanted in Remission

Disease Risk and Host Factors, Not Transplant Type, Predict Outcome Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia

Factors Predicting Gvhd Free, Relapse Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation; A Multivariable Analysis of 531 Allografts from a Single Center

T Cell Replete HLA- Haploidentical Donor Transplantation (HIDT) with Post-Transplant Cyclophosphamide (pTcy) Is an Effective Salvage for Patients Relapsing after a Matched Sibling or a Matched Unrelated Donor Transplantation

Targeted Oral Busulfan (BU)/Cyclophosphamide (CY)/VP-16 and Autologous Stem Cell Transplant (ASCT) for Hodgkin's (HL) and Non-Hodgkin's Lymphoma (NHL) Results in Excellent 5-Year Survival and Low Treatment-Related Mortality: Ten-Year Single Center Experience of 246 Consecutively Treated Patients

TBI-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients without Matched Sibling Donors

Chronic GVHD Is Not Increased with the Use of PBSC Instead of Bone Marrow for T-Replete HLA-Haploidentical Transplanation Using Post-Transplant Cyclophosphamide : A Multivartiate Analysis of 116 Consecutive Transplants from a Single Center

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only